# Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy

> **NCT03590730** · — · TERMINATED · sponsor: **Keimyung University Dongsan Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Valvular Heart Disease
- Implantable Cardioverter Defibrillator
- Sudden Cardiac Death
- Primary Prevention

## Interventions

- **DEVICE:** ICD implantation

## Key facts

- **NCT ID:** NCT03590730
- **Lead sponsor:** Keimyung University Dongsan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-15
- **Primary completion:** 2019-07-10
- **Final completion:** 2021-07-15
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** The trial stopped prematurely because of enrollment challenges.
- **Last updated:** 2023-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03590730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03590730, "Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03590730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*